Anti-PD1(RetifanlimAb biosimilar) monoclonal Antibody
Figure 1: Coomassie Gel loaded with 5 ug of purified ZYNYZ biosimilar under reducing condition.
Roll over image to zoom in
Shipping Info:
Order now and get it on Friday November 22, 2024
Same day delivery FREE on San Diego area orders placed by 1.00 PM
| Amount : | 100 µg |
| Isotype : | IgG4(P108S) |
| Content : | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Reconstitute in sterile water. |
| Storage condition : | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature. |
| Alternative Name : | Zynyz |
Retifanlimab (Zynyz), is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Monoclonal antobody. Retifanlimab blocks the interaction between PD-1 and its ligands PD-L1/2, and it acts as an immune checkpoint modulator.
FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
|
There are currently no product reviews
|
.png "ACE2/HEK293 Stable Cell Line")
